Diabetes complications

A Deep Learning Prognostic Model for Diabetes Patients Using Bilateral Fundus Imaging

J Diabetes Sci TechnolPublished Prognostic model development study

Authors' conclusion

We developed a survival-aware, image-based model that can predict mortality risk directly from routine fundus photography, achieving prognostic discrimination which facilitates diabetes management.

Study context

Population
Persons with DM who received routine color fundoscopy examinations
Participants
19,029 persons
Comparison
Image-trained mortality model risk quartiles vs lowest-risk quartile; comparison with a regulatory-approved commercial ophthalmic system
Outcome
Mortality
Methodological detailsdeep learning, Cox proportional hazards modeling
  • Deep learning
  • Cox proportional hazards modeling

Performance

As reported in the abstract

Mortality by image-trained model risk quartile, testing cohort
Hazard ratio (95% CI)
Second-lowest-risk quartilevs Lowest-risk quartile
1.67(0.80–3.47)
Second-highest-risk quartilevs Lowest-risk quartile
3.02(1.55–5.88)
Highest-risk quartilevs Lowest-risk quartile
7.19(3.91–13.25)
5-year survival rate of highest-risk quartile
lower than 80%

Further findings

Commercial ophthalmic system strata, mortality

Hazard ratios (HRs) across commercial system strata
1.48, 2.02, and 3.11

Model in strata of equivalent sizes to commercial system, mortality

HR
3.64 (3.18-4.16) (95% CI)
HR
4.98 (4.08-6.07) (95% CI)
HR
6.89 (6.01-7.89) (95% CI)
Stronger separation than the commercial system

5-year survival of top 8% patients identified by the model

5-year survival rate
<70%

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

A Deep Learning Prognostic Model for Diabetes Patients Using Bilateral Fundus Imaging. J Diabetes Sci Technol. Published 29 March 2026. doi:10.1177/19322968261434035

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.